| 发明名称 |
Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(MSC) |
| 摘要 |
<p>The present invention provides a method for determining the clinical prognosis of a human subject to the administration of a pharmaceutical composition comprising of stem cells (preferably mesenchymal stem cells), stromal cells,regulatory T-cells, fibroblasts and combinations thereof.</p> |
| 申请公布号 |
AU2014230014(A1) |
申请公布日期 |
2015.10.29 |
| 申请号 |
AU20140230014 |
申请日期 |
2014.03.17 |
| 申请人 |
TIGENIX, S.A.U;TIGENIX NV |
发明人 |
DE LA ROSA, OLGA;LOMBARDO, ELEUTERIO;DALEMANS, WILFRIED |
| 分类号 |
G01N33/569;A61K35/14;A61P37/06 |
主分类号 |
G01N33/569 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
